Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits mild hemolytic activities against human erythrocytes (16 uM induce 70% of hemolysis). Furthermore, this peptide potently inhibits the growth of vancomycin-resistant Enterococcus (VRE) S13, a pathogen that can cause a number of human infections. Minimal inhibitory concentration (MIC) are the following: 16 uM against S.aureus, 6 uM against B.magaterium, 8 uM against M.luteus, 4 uM against VRE, 12 uM against methicillin-resistant S.aureus, 36 uM against E.coli, >87 uM against P.putida, 87 uM against K.oxytoca, >87 uM against E.cloacae, 84 uM against S.enterica and 17 uM against the fungus C.tropicalis. Forms an alpha-helical membrane channel in the prey. Expressed by the venom gland. Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. Short antimicrobial peptide (group 4) family.